Cipher Pharmaceuticals Q3 2026 Results: Epuris Sales Rise 15%, Natroba Gains 14% as Net Income Hits $10.9M
Cipher Pharmaceuticals Q3 2026 results show net revenue of $12.7 million, net income of $10.9 million, Epuris sales up 15% and Natroba up 14% sequentially, plus a $5.7 million arbitration collection.
